IP Library Granted Patent US 9,884,912
Granted Patent B2
US 9,884,912 · App. 14/546,074 · Granted Feb 6, 2018

Antibodies to IL-6 and use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,884,912
App. No.
14/546,074
Granted
Feb 6, 2018
Kind
B2
Abstract

The present invention is directed to antibodies and fragments thereof and humanized versions thereof having binding specificity for IL-6. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V H , V L and CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-IL-6 antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-IL-6 antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-IL-6 antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with IL-6. These antibodies may bind at least one of soluble IL-6, cell surface expressed IL-6, IL-6/IL-6R and/or prevent the association of IL-6 and IL-6R, the association of IL-6/IL-6R and gp130 and or the formation of IL-6/IL-6R/gp130 multimers and thereby inhibit a biological effect associated with any of the foregoing.

Claims (13)

1. An isolated polynucleotide comprising a nucleic acid sequence encoding a heavy chain polypeptide or variable heavy chain polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:2, 20, 702, 706 and 709; and a nucleic acid sequence encoding a light chain polypeptide or variable light chain polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:3, 18, 19, 657, 658, 704 and 708.

2. The polynucleotide of claim 1 where yeast or human preferred codons are used.

3. A vector comprising the isolated polynucleotide of claim 1 .

4. A recombinant cell which comprises the isolated polynucleotide of claim 1 .

5. The isolated polynucleotide of claim 1 where the light chain polypeptide is encoded by SEQ ID NO:701 or SEQ ID NO:705 and the heavy chain polypeptide is encoded by SEQ ID NO:703 or 707.

6. The isolated polynucleotide of claim 1 where the light chain polypeptide is encoded by SEQ ID NO:701 and the heavy chain polypeptide is encoded by SEQ ID NO:703.

7. The isolated polynucleotide of claim 1 where the light chain polypeptide is encoded by SEQ ID NO:705 and the heavy chain polypeptide is encoded by SEQ ID NO:707.

8. The isolated polynucleotide of claim 1 where the light chain polypeptide is encoded by SEQ ID NO:705 and the heavy chain polypeptide is encoded by SEQ ID NO:703.

9. The isolated polynucleotide of claim 1 where the light chain polypeptide is encoded by SEQ ID NO:701 and the heavy chain polypeptide is encoded by SEQ ID NO:707.

10. An isolated polynucleotide comprising a nucleic acid sequence encoding an amino acid sequence selected from SEQ ID NOS: 2, 3, 18, 19, 20, 702, 704, 706, 708 and 709.

11. The isolated polynucleotide of claim 10 where yeast or human preferred codons are used.

12. A vector comprising the isolated polynucleotide of claim 10 .

13. A recombinant cell comprising the isolated polynucleotide of claim 10 .

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2020
From: H. LUNDBECK A/S
To: VITAERIS INC.
Reel/Frame 053496/0319 →
CHANGE OF NAME Recorded Jun 23, 2020
From: ALDER BIOPHARMACEUTICALS, INC.
To: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC.
Reel/Frame 053020/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2020
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S
Reel/Frame 053020/0205 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2015
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALDERBIO HOLDINGS LLC
Reel/Frame 034777/0728 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2014
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALDERBIO HOLDINGS LLC
Reel/Frame 034491/0663 →